# Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia

> **NCT01256476** · PHASE4 · COMPLETED · sponsor: **Kowa Research Institute, Inc.** · enrollment: 328 (actual)

## Conditions studied

- Primary Dyslipidemia
- Mixed Dyslipidemia

## Interventions

- **DRUG:** pitavastatin
- **DRUG:** pravastatin

## Key facts

- **NCT ID:** NCT01256476
- **Lead sponsor:** Kowa Research Institute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 328 (ACTUAL)
- **Last updated:** 2012-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01256476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01256476, "Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01256476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*